Summary of Significant Accounting Policies - Schedule of Revision of Previously Issued Financial Statements (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Condensed Consolidated Balance Sheet
Additional paid-in capital	$ 302,573				$ 302,573		$ 292,082
Accumulated deficit	(202,708)				(202,708)		(149,232)
Condensed Consolidated Statement of Comprehensive Loss
Cost of Revenue	37,233		$ 66,158		96,073	$ 131,746
Research and development	2,711		5,583		5,412	7,537
Selling and marketing	2,927		3,097		4,899	4,197
General and administrative	13,089		47,742		26,907	52,826
Total operating expenses	18,727		56,422		37,218	64,560
Loss from operations	(25,239)		(72,472)		(53,017)	(80,491)
Loss before income taxes	(25,593)		(52,235)		(53,310)	(59,696)
Net loss	(25,683)	$ (27,793)	(52,350)	$ (7,442)	(53,476)	(59,792)
Comprehensive loss	$ (25,623)		$ (52,343)		$ (53,359)	$ (59,786)
Basic loss per share	$ (0.26)		$ (0.61)		$ (0.54)	$ (0.78)
Diluted loss per share	$ (0.26)		$ (0.61)		$ (0.54)	$ (0.78)
Basic weighted-average number of common shares outstanding	100,321,943		86,156,309		99,752,707	76,581,517
Diluted weighted-average number of common shares outstanding	100,321,943		86,156,309		99,752,707	76,581,517
Statement of Stockholders' Equity [Abstract]
Net Income (loss)	$ (25,683)	(27,793)	$ (52,350)	(7,442)	$ (53,476)	$ (59,792)
Stockholders equity	99,999	120,168	180,772	496	99,999	180,772	142,866	$ 7,451
Statement of Cash Flows [Abstract]
Net loss	(25,683)	(27,793)	(52,350)	(7,442)	(53,476)	(59,792)
Note 11. Net loss per share
Net Income (Loss) Attributable to Parent	$ (25,683)	(27,793)	$ (52,350)	(7,442)	$ (53,476)	$ (59,792)
Weighted Average Number of Shares Outstanding, Basic	100,321,943		86,156,309		99,752,707	76,581,517
Weighted Average Number of Shares Outstanding, Diluted	100,321,943		86,156,309		99,752,707	76,581,517
Earnings Per Share, Basic	$ (0.26)		$ (0.61)		$ (0.54)	$ (0.78)
Earnings Per Share, Diluted	$ (0.26)		$ (0.61)		$ (0.54)	$ (0.78)
Potential common shares excluded from diluted net loss per share					15,970,208	13,346,487
Product
Condensed Consolidated Statement of Comprehensive Loss
Cost of Revenue	$ 16,426		$ 43,878		$ 51,389	$ 98,874
Additional Paid-in Capital
Statement of Stockholders' Equity [Abstract]
Stockholders equity	302,573	297,119	283,196	50,584	302,573	283,196	292,082	50,096
Accumulated Deficit
Condensed Consolidated Statement of Comprehensive Loss
Net loss	(25,683)	(27,793)	(52,350)	(7,442)
Statement of Stockholders' Equity [Abstract]
Net Income (loss)	(25,683)	(27,793)	(52,350)	(7,442)
Stockholders equity	(202,708)	(177,025)	(102,435)	(50,085)	$ (202,708)	(102,435)	$ (149,232)	$ (42,643)
Statement of Cash Flows [Abstract]
Net loss	(25,683)	(27,793)	(52,350)	(7,442)
Note 11. Net loss per share
Net Income (Loss) Attributable to Parent	$ (25,683)	$ (27,793)	(52,350)	$ (7,442)
As Previously Reported
Condensed Consolidated Balance Sheet
Additional paid-in capital			286,687			286,687
Accumulated deficit			(105,926)			(105,926)
Condensed Consolidated Statement of Comprehensive Loss
Research and development			5,585			7,539
Selling and marketing			3,258			4,358
General and administrative			51,063			56,147
Total operating expenses			59,906			68,044
Loss from operations			(75,963)			(83,982)
Loss before income taxes			(55,726)			(63,187)
Net loss			(55,841)			(63,283)
Comprehensive loss			$ (55,834)			$ (63,277)
Basic loss per share			$ (0.70)			$ (0.87)
Diluted loss per share			$ (0.70)			$ (0.87)
Basic weighted-average number of common shares outstanding			79,229,174			73,106,935
Diluted weighted-average number of common shares outstanding			79,229,174			73,106,935
Statement of Stockholders' Equity [Abstract]
Net Income (loss)			$ (55,841)			$ (63,283)
Stock-based compensation			56,192			56,641
Statement of Cash Flows [Abstract]
Net loss			(55,841)			(63,283)
Stock-based compensation			56,192			56,641
Note 11. Net loss per share
Net Income (Loss) Attributable to Parent			$ (55,841)			$ (63,283)
Weighted Average Number of Shares Outstanding, Basic			79,229,174			73,106,935
Weighted Average Number of Shares Outstanding, Diluted			79,229,174			73,106,935
Earnings Per Share, Basic			$ (0.70)			$ (0.87)
Earnings Per Share, Diluted			$ (0.70)			$ (0.87)
Shares of common stock issuable upon vesting of restricted stock awards						15,078,870
Potential common shares excluded from diluted net loss per share						23,231,229
As Previously Reported | Product
Condensed Consolidated Statement of Comprehensive Loss
Cost of Revenue			$ 43,885			$ 98,881
As Previously Reported | Additional Paid-in Capital
Condensed Consolidated Balance Sheet
Additional paid-in capital			286,687			286,687
As Previously Reported | Accumulated Deficit
Condensed Consolidated Balance Sheet
Accumulated deficit			(105,926)			(105,926)
Adjustments
Condensed Consolidated Balance Sheet
Additional paid-in capital			(3,491)			(3,491)
Accumulated deficit			3,491			3,491
Condensed Consolidated Statement of Comprehensive Loss
Research and development			(2)			(2)
Selling and marketing			(161)			(161)
General and administrative			(3,321)			(3,321)
Total operating expenses			(3,484)			(3,484)
Loss from operations			3,491			3,491
Loss before income taxes			3,491			3,491
Net loss			3,491			3,491
Comprehensive loss			$ 3,491			$ 3,491
Basic loss per share			$ 0.09			$ 0.09
Diluted loss per share			$ 0.09			$ 0.09
Basic weighted-average number of common shares outstanding			6,927,135			3,474,582
Diluted weighted-average number of common shares outstanding			6,927,135			3,474,582
Statement of Stockholders' Equity [Abstract]
Net Income (loss)			$ 3,491			$ 3,491
Stock-based compensation			(3,491)			(3,491)
Statement of Cash Flows [Abstract]
Net loss			3,491			3,491
Stock-based compensation			(3,491)			(3,491)
Note 11. Net loss per share
Net Income (Loss) Attributable to Parent			$ 3,491			$ 3,491
Weighted Average Number of Shares Outstanding, Basic			6,927,135			3,474,582
Weighted Average Number of Shares Outstanding, Diluted			6,927,135			3,474,582
Earnings Per Share, Basic			$ 0.09			$ 0.09
Earnings Per Share, Diluted			$ 0.09			$ 0.09
Shares of common stock issuable upon vesting of restricted stock awards						(9,884,742)
Potential common shares excluded from diluted net loss per share						(9,884,742)
Adjustments | Product
Condensed Consolidated Statement of Comprehensive Loss
Cost of Revenue			$ (7)			$ (7)
Adjustments | Additional Paid-in Capital
Condensed Consolidated Balance Sheet
Additional paid-in capital			(3,491)			(3,491)
Adjustments | Accumulated Deficit
Condensed Consolidated Balance Sheet
Accumulated deficit			3,491			3,491
As Revised
Condensed Consolidated Balance Sheet
Additional paid-in capital			283,196			283,196
Accumulated deficit			(102,435)			(102,435)
Condensed Consolidated Statement of Comprehensive Loss
Research and development			5,583			7,537
Selling and marketing			3,097			4,197
General and administrative			47,742			52,826
Total operating expenses			56,422			64,560
Loss from operations			(72,472)			(80,491)
Loss before income taxes			(52,235)			(59,696)
Net loss			(52,350)			(59,792)
Comprehensive loss			$ (52,343)			$ (59,786)
Basic loss per share			$ (0.61)			$ (0.78)
Diluted loss per share			$ (0.61)			$ (0.78)
Basic weighted-average number of common shares outstanding			86,156,309			76,581,517
Diluted weighted-average number of common shares outstanding			86,156,309			76,581,517
Statement of Stockholders' Equity [Abstract]
Net Income (loss)			$ (52,350)			$ (59,792)
Stock-based compensation			52,701			53,150
Statement of Cash Flows [Abstract]
Net loss			(52,350)			(59,792)
Stock-based compensation			52,701			53,150
Note 11. Net loss per share
Net Income (Loss) Attributable to Parent			$ (52,350)			$ (59,792)
Weighted Average Number of Shares Outstanding, Basic			86,156,309			76,581,517
Weighted Average Number of Shares Outstanding, Diluted			86,156,309			76,581,517
Earnings Per Share, Basic			$ (0.61)			$ (0.78)
Earnings Per Share, Diluted			$ (0.61)			$ (0.78)
Shares of common stock issuable upon vesting of restricted stock awards						5,194,128
Potential common shares excluded from diluted net loss per share						13,346,487
As Revised | Product
Condensed Consolidated Statement of Comprehensive Loss
Cost of Revenue			$ 43,878			$ 98,874
As Revised | Additional Paid-in Capital
Condensed Consolidated Balance Sheet
Additional paid-in capital			283,196			283,196
As Revised | Accumulated Deficit
Condensed Consolidated Balance Sheet
Accumulated deficit			$ (102,435)			$ (102,435)